MTAP deletions, which occur in approximately 10 to 30 percent of all cancers, lead to elevated levels of MTA in tumour cells and BAY 3713372 is designed to bind the PRMT5-MTA complex thus specifically ...
MTAP deletions, which occur in approximately 10 to 30 percent of all cancers, lead to elevated levels of MTA in tumor cells and BAY 3713372 is designed to bind the PRMT5-MTA complex thus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback